INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: Yes, for EGFR mutation analysis, others, I PASS

Ramaswamy Govindan

doi:10.1200/JCO.2009.25.1637

INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: Yes, for EGFR mutation analysis, others, I PASS

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	713-715
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	28
Issue number	5
DOIs	https://doi.org/10.1200/JCO.2009.25.1637
State	Published - Feb 10 2010

Access to Document

10.1200/JCO.2009.25.1637

Cite this

@article{638ed0e19bcd4de1954e090c277e7b08,

title = "INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: Yes, for EGFR mutation analysis, others, I PASS",

author = "Ramaswamy Govindan",

year = "2010",

month = feb,

day = "10",

doi = "10.1200/JCO.2009.25.1637",

language = "English",

volume = "28",

pages = "713--715",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "5",

}

TY - JOUR

T1 - INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors

T2 - Yes, for EGFR mutation analysis, others, I PASS

AU - Govindan, Ramaswamy

PY - 2010/2/10

Y1 - 2010/2/10

UR - http://www.scopus.com/inward/record.url?scp=77649213892&partnerID=8YFLogxK

U2 - 10.1200/JCO.2009.25.1637

DO - 10.1200/JCO.2009.25.1637

M3 - Editorial

C2 - 20038722

AN - SCOPUS:77649213892

SN - 0732-183X

VL - 28

SP - 713

EP - 715

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 5

ER -

INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: Yes, for EGFR mutation analysis, others, I PASS

Access to Document

Other files and links

Cite this